Amsterdam, Netherlands

Katarina Franke

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Byondis B.v.. Active years: 2022-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katarina Franke. Retrieved from https://idiyas.com/inventor/katarina-franke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Katarina Franke: Pioneering Anti-Cancer Antibodies**

Introduction

Katarina Franke is an innovative inventor based in Amsterdam, Netherlands, who has made significant contributions to anti-cancer therapies through her groundbreaking research. With two patents to her name, she represents a key figure in the field of medical technology and biotechnology.

Latest Patents

Katarina's recent patents focus on anti-SIRPα antibodies, which are designed to target SIRPα for use in anti-cancer therapy. These inventions enhance the treatment of human solid tumors and hematological malignancies, either independently or in combination with other anti-cancer therapies. The anti-SIRPα antibodies she has developed exhibit remarkable specificity and affinity for both SIRPα1 and SIRPαBIT, distinguishing them from existing anti-SIRPα antibodies. Notably, they do not interact with SIRPγ or SIRPβ, thereby offering a more targeted therapeutic approach.

Career Highlights

Katarina Franke is associated with Byondis B.V., a company at the forefront of developing innovative therapeutic solutions. Her work has not only advanced the technology surrounding cancer treatments but has also opened new avenues for research in the field. Her expertise and dedication highlight her as a leading figure in her industry.

Collaborations

Throughout her career, Katarina has collaborated with esteemed colleagues such as Gijsbertus Franciscus Maria Verheijden and Gerard Rouwendal. These partnerships have played a crucial role in the development and success of her patents, showcasing the collaborative nature of innovation in the biotechnology sector.

Conclusion

Katarina Franke's contributions to the development of anti-SIRPα antibodies position her as a notable inventor in the medical field. Her work has the potential to significantly impact cancer therapy and exemplifies the importance of innovation in addressing complex health challenges. With her dedication and expertise, Katarina is undoubtedly set to continue making strides in her area of specialization.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…